Drug-SNPing

Allows the study of drug-related single nucleotide polymorphisms (SNP) interactions and related genotyping. Drug-SNPing is a pharmacogenomics-based and protein interaction-based platform for SNP genotyping information. The software provides connections between the tools DrugBank for chemoinformatics, pharmGKB for pharmacogenomics, STRING for protein–protein interaction, genotyping information for TaqMan probes and PCR-restriction enzyme length polymorphism (PCR-RFLP). It can be useful for the development of pharmacogenomics as part of personalized medicine.

Drug-SNPing specifications

Information

Unique identifier

OMICS_25430

Name

Drug-SNPing

Interface

Web user interface

Restrictions to use

None

Input data

Some DrugBank-based inputs (Drug common name, synonym or drug brand name, gene name (HUGO; official symbol in GenBank), and other key words, or PharmGKB-based inputs (gene name (HUGO, official gene symbol), drug name, and disease related keywords).

Supported by National Science Council in Taiwan (grants NSC101-2622-E-151-027-CC3, NSC100-2221-E-214-071, NSC98-2622-E151-001-CC2 and NSC101-2221-E-464-001, and the funds of the Department of Health, Executive Yuan, R.O.C. (TAIWAN) (DOH102-TD-C-111-002); the Kaohsiung Medical University Research Foundation (KMUER001); the NSYSU-KMU JOINT RESEARCH PROJECT (#NSYSUKMU 102-034; and the I-Shou University plan (ISU100-02-05).